VOGLIZOME 0.2
VOGLIZOME contains Voglibose, an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. Voglibose works by delaying the absorption of carbohydrates from the digestive tract, which helps to prevent postprandial (after-meal) blood glucose spikes. By inhibiting the alpha-glucosidase enzyme, Voglibose slows down the breakdown of complex carbohydrates into simpler sugars, leading to a more gradual rise in blood glucose levels.
| SKU: | 002 |
| category: | vitamins |
| tags: | suppliments |
Composition
Each tablet contains:
| Voglibose: | 0.2 mg. |
Blood Sugar Control: Helps manage postprandial blood glucose levels by slowing carbohydrate
absorption, reducing after-meal glucose spikes.
Improves Glycemic Control: Used in combination with other antidiabetic medications to enhance
overall glycemic control.
Reduces Insulin Requirements: By managing postprandial glucose spikes, it can help in
reducing the need for higher doses of insulin or other antidiabetic medications.
Low Risk of Hypoglycemia: Unlike some other diabetes medications, Voglibose has a lower risk
of causing hypoglycemia (low blood sugar) when used alone.
Flatulence (gas accumulation)
Abdominal bloating
Hypoglycemia (low blood sugar when combined with other antidiabetics)